Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Market: Pharmaceuticals and Healthcare

Global, 183 pages report, published by GBI Research

Report ThumbnailNovember-2016
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Summary

Cancer vaccines are being developed as a method of preventing certain types of cancer, and as therapeutic treatments to treat existing cancers across a range of indications in oncology, either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. The high mortal

Read More
  • 1.2 List of Figures
  • Figure 1: Cancer Vaccines Market, Major Markets, Treatment Usage Patterns for Cervical Cancer, Patients (‘000), 2015-2022 17
  • Figure 2: Cancer Vaccines Market, Major Markets, Treatment Usage Patterns for Liver Cancer, Patients (‘000), 2015-2022 18
  • Figure 3: Cancer Vaccines Market, Major Markets, Treatment Usage Patterns for Melanoma, Patients (‘000), 2015-2022 19
  • Figure 4: Cancer Vaccines Market, Major Markets, Treatment Usage Patterns for Prostate Cancer, Patients (‘000), 201
Read More
  • 1.1 List of Tables
  • Table 1: Cancer Vaccines Market, Global, Symptoms of Key Indication Cancers, 2016 12
  • Table 2: Cancer Vaccines Market, Global, Infectious Agents and Associated Cancers, 2016 14
  • Table 3: Cancer Vaccines Market, Global, Epidemiology of Key Oncology Indications, 2016 16
  • Table 4: Cancer Vaccines Market, Complications Associated with Cervical, Liver, Melanoma and Prostate Cancers, 2016 21
  • Table 5: Cancer Vaccines Market, Optimal Chemotherapy Usage Rates 25
  • Table 6: Cancer Vaccines M
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 7
  • 1.2 List of Figures 7
  • 2 Introduction 10
  • 2.1 Therapy Area Introduction 10
  • 2.2 Symptoms 11
  • 2.3 Etiology and Pathophysiology 12
  • 2.3.1 Etiology 12
  • 2.3.2 Cancer Pathophysiology 14
  • 2.3.3 Virus Pathophysiology 15
  • 2.4 Epidemiology Patterns - Prevalence, Patient Segmentation, and Diagnostic and Treatment Usage Rates 16
  • 2.4.1 Cervical Cancer 17
  • 2.4.2 Liver Cancer 17
  • 2.4.3 Melanoma 18
  • 2.4.4 Prostate Cancer 19
  • 2.5 Co-morbidities and Complication
Read More

Related Products

GBI ResearchGlobal Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19Product ThumbnailGlobal Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19, Industry ReportProduct #: 613642
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved